CompanyInvestor RelationsStem Cell StorageCell ExpansionCell TherapiesResearch and DevelopmentCompany NewsScientific NewsContact
    
 
  • Company
  • Shareholder
  • Share Price
  • Analyst
  • Financial Reporting
  • Accounting policies
  • Calendar
  • Investor News
  • Presentations and news
  • Contact
    		•
    Investor Relations / Investor News

    EGM resolutions and share consolidation (06/10/2009)

    This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is not an offer of securities in the United States, Canada, South Africa, Australia, Japan or any other jurisdiction.

    Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, announces that all resolutions at today’s EGM were passed.

    The Group is on course to secure its additional listing on Euronext Amsterdam by mid October to complement the Group’s shares being traded on AIM in London. Cryo-Save will not be issuing any new shares or raising new funds.

    Following the adoption of the first amendment of the Articles of Association at today’s EGM, the 5:1 consolidation and redenomination of the shares is expected to take place following the close of trading of the shares on AIM on 7 October 2009. As a consequence of the share consolidation, for every five shares with a nominal value of 2 euro cents held by a shareholder immediately prior to the close of trading on 7 October 2009, a shareholder will hold one share with a nominal value of 10 euro cents.

    Immediately after the share consolidation, the Group will have a total number of 9,639,191 issued shares, each with a nominal value of 10 euro cents.

    The information contained herein is not for publication or distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any State of the United States and the District of Columbia). These materials do not contain or constitute an offer for sale or the solicitation of an offer to purchase securities in the United States or any other jurisdiction. The securities mentioned herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration under the Securities Act or an available exemption from, or transaction not subject to, the registration requirements of the Securities Act.

     

    This announcement is not a prospectus. In connection with the admission of the shares in the capital of the Company to trading on Euronext Amsterdam by NYSE Euronext, a prospectus shall in due course be made generally available. Copies of the Prospectus will, following publication, be available at no cost through the website of the Company (www.cryo-savegroup.com) and the website of Euronext Amsterdam (Dutch residents only) and by sending a request in writing to the Company at its business address: IJsselkade 8, 7201 HB Zutphen, the Netherlands.

     

    For further details:

    Cryo-Save Group                                          + 31 (0)575 548 998
    Marc Waeterschoot, Chief Executive
    Arnoud van Tulder, Chief Financial Officer

    Daniel Stewart & Company plc                    + 44 (0) 20 7776 6550
    Simon Leathers/Charlotte Stranner

    College Hill                                                   + 44 (0) 20 7457 2020
    Adrian Duffield/Rozi Morris

    Announcements

    Date Title Summary 
    26/08/2010Half Year Results 2010 (UK)Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's leading adult stem cell storage bank, has published its interim results for the six months ended 30 June 2010.
    26/08/2010Half Year Results 2010 (Dutch)Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', of 'de Groep'), de grootste stamcelbank van Europa, heeft haar resultaten voor de eerste helft van 2010 bekendgemaakt.
    06/08/2010Appointment Liquidity Provider (English)Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, today announces that it has decided to appoint Kempen & Co as liquidity provider as of 2 August 2010.
    06/08/2010Benoeming Liquidity Provider (Dutch)Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, maakt vandaag bekend Kempen & Co per 2 augustus 2010 te hebben benoemd als liquidity provider.
    02/08/2010Director/PDMR Shareholding (UK)Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Marc Waeterschoot, Executive Director, purchased 23,850 ordinary shares of Euro 0.10 (‘Ordinary Shares’)...
    02/08/2010Director/PDMR Shareholding (Dutch)Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, is vandaag geïnformeerd dat de heer Marc Waeterschoot, Executive Director, 23.850 aandelen Cryo-Save heeft gekocht in de periode van 26 juli tot en met 30 juli.
    27/07/2010Director/PDMR ShareholdingCryo-Save Group N.V.(Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Walter van Pottelberge, Non-Executive Director, purchased 10,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at €5.70 on 26 July 2010.
    27/07/2010Director/PDMR Shareholding (Dutch version)Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, is vandaag geïnformeerd dat de heer Walter van Pottelberge, Non-Executive Director, 10.000 aandelen Cryo-Save heeft gekocht tegen €5,70 op 26 juli 2010.
    27/07/2010Director/PDMR Shareholding (Dutch version)Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, is vandaag geïnformeerd dat de heer Johan Goossens, Chairman, 16.000 aandelen Cryo-Save heeft gekocht tegen €5,78 op 26 juli 2010.
    27/07/2010Director/PDMR ShareholdingCryo-Save Group N.V.(Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Johan Goossens, Chairman, purchased 16,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at €5.78 on 26 July 2010.
    21/07/2010Egypt and France announcement 1HY 2010Contract signed with Egyptian partner; update on France and announcement of interim results...
    04/06/2010Scientists give go-ahead for private storageFour world-renowned stem cell experts have recently given their full support to private cordblood banking. The four scientists supported the "Family Cord Blood Bank" which has just been established in the US by CORD:USE.
    04/06/2010Scientists give go-ahead for private storage (Dutch version)Vier wereldvermaarde stamcelexperts* en initiatiefnemers van publieke celopslagbanken in de Verenigde Staten en Europa, hebben zich recent duidelijk uitgesproken voor de opslag van stamcellen uit navelstrengbloed in private banken. De oprichting van de ‘family Cord Blood Bank’ door CORD:USE in de VS, mocht zich verheugen in de enthousiaste medewerking van deze wetenschappeliijke experts.
    02/06/2010Cancellation noticeCryo-Save Group N.V. (AIM/Euronext: CRYO, 'Cryo-Save'; or 'the Group'), announces that further to the statement made by the Group on 22 March 2010 regarding the intention to delist its ordinary shares from trading on AIM, the Group today announces that its admission to trading on AIM will be cancelled with effect from 30 June 2010.
    28/05/2010Spain and France UpdateCryo-Save Group N.V. (AIM/Euronext: 'Cryo-Save' or 'the Group'), Europe's leading stem cell bank, announces the signing of the contract with Aresa Seguros de Salud, the health insurance company of the Spanish Mutua Madrilena Insurance Group.
    21/05/2010Cryo-Lip LaunchCryo-Save Group N.V. (Euronext/AIM: CRYO, 'Cryo-Save' or 'the Group'), Europe's leading stem cell bank, announces the European launch of Cryo-Lip®, a new product that allows the collection, processing and storage of a rich mixture of adult stem cells from liposuction aspirate (fatty tissue that is normally discarded). A new cryopreservation process for fatty tissue has been developed and submitted for international patent by Cryo-Save.
    21/05/2010Cryo-Lip Launch (Dutch version)Cryo-Save Group N.V. (Euronext/AIM: CRYO, “Cryo-Save” of “de Groep”), Europa’s grootste stamcelbank, maakt de Europese introductie bekend van Cryo-Lip®, een nieuw product waarmee een rijk mengsel van volwassen stamcellen uit liposuctievet (vetweefsel dat normaal gesproken wordt weggegooid) kan worden verzameld, verwerkt en opgeslagen. Cryo-Save heeft een nieuw cryopreservatieproces (bewaring bij zeer lage temperaturen) voor vetweefsel ontwikkeld en hiervoor een internationale octrooiaanvraag ingediend.
    19/05/2010AGM Result 19 May 2010Cryo-Save Group N.V. (Euronext/AIM: CRYO, 'Cryo-Save' or 'the Group'), Europe's leading stem cell bank, announces that all resolutions at today's AGM were passed.
    19/05/2010AGM Result 19 May 2010 (Dutch version)Cryo-Save Group N.V. (Euronext/AIM: CRYO, 'Cryo-Save' of 'de Groep'), Europa's grootste stamcelbank, maakt bekend dat alle voorstellen aan de Algemene Vergadering van Aandeelhouders, welke hedenmiddag plaatsvond te Zutphen, zijn aangenomen.
    17/05/2010Director/PDMR ShareholdingCryo-Save Group N.V.(AIM/Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's leading stem cell bank, has been informed today that Mr Johan Goossens, Chairman, purchased 25,000 ordinary shares of Euro 0.10 ('Ordinary Shares') at €5.78 on 14 May 2010.
    17/05/2010Director/PDMR Shareholding (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, 'Cryo-Save', of 'de Groep'), de grootste stamcelbank van Europa is vandaag geïnformeerd dat de heer Johan Goossens, Chairman, 25.000 aandelen Cryo-Save heeft gekocht tegen €5,78 op 14 mei 2010.
    10/05/2010Trading update Q1 2010Cryo-Save Group N.V. (AIM/Euronext: CRYO, or 'the Group'), Europe's leading stem cell bank, announces its trading update for the three months to 31 March 2010.
    10/05/2010Trading update Q1 2010 (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, of 'de Groep'), de grootste stamcelbank van Europa, publiceert vandaag haar trading update over het eerste kwartaal van 2010.
    04/05/2010Notice of Annual General Meeting 2010Cryo-Save Group N.V. (AIM/Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's leading stem cell bank, announces that the Group's Annual General Meeting (AGM) will be held on Wednesday, 19 May 2010 at 14:00 hours CET at IJsselpaviljoen, IJsselkade 1, 7201 HA Zutphen, the Netherlands.
    04/05/2010Annual General Meeting 2010 (Dutch Version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, of ’de Groep’), de grootste stamcelbank van Europa maakt bekend dat haar Algemene Vergadering van Aandeelhouders zal worden gehouden op woensdag 19 mei 2010, aanvang om 14:00 uur in het IJsselpaviljoen, IJsselkade 1, 7201 HA te Zutphen.
    29/04/2010Toekenning aandelen optiesCryo-Save Group N.V. (AIM/Euronext: CRYO, of ’de Groep’), de grootste stamcelbank van Europa maakt bekend dat door de Groep op 28 april 2010 opties zijn toegekend op haar aandelen onder het 2009 Share Option Scheme.
    29/04/2010Grant of share optionsCryo-Save Group N.V. (AIM/Euronext: CRYO, ‘Cryo-Save’ or ‘the Group’), Europe's leading stem cell bank, announces that on 28 April 2010 the Group granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2009 Share Option Scheme.
    19/04/2010Publicatie Jaarverslag 2009Cryo-Save Group N.V. (AIM/Euronext: CRYO, of “de Groep”), de grootste stamcelbank van Europa bevestigt dat het jaarverslag over het boekjaar eindigend op 31 december 2009 elektronisch beschikbaar is op haar website www.cryo-savegroup.com.
    19/04/2010Annual Report and Accounts 2009Cryo-Save Group N.V. (AIM/Euronext: CRYO, or "the Group"), Europe's leading stem cell bank, confirms that its annual report and accounts for the year ended 31 December 2009 is now available on the Group's website, www.cryo-savegroup.com.
    12/04/2010Director/PDMR ShareholdingCryo-Save Group N.V.(AIM/Euronext: CRYO, or ‘the Group’), Europe’s leading stem cell bank, has been informed that Mr Marc Waeterschoot, Chief Executive Officer, purchased 17,296 ordinary shares.
    12/04/2010Director/PDMR Shareholding (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, of “de Groep”), de grootste stamcelbank van Europa is geïnformeerd dat de heer Marc Waeterschoot, Chief Executive Officer, 17.296 aandelen Cryo-Save heeft gekocht in de periode van 7 april tot en met 9 april 2010.
    30/03/2010Director/PDMR ShareholdingCryo-Save Group N.V.(AIM/Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Johan Goossens, Chairman, purchased 17,873 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price range between €5.60 and €5.84 between 23 March and 26 March 2010.
    30/03/2010Director/PDMR Shareholding (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save”, of “de Groep”), de grootste stamcelbank van Europa is vandaag geïnformeerd dat de heer Johan Goossens, Chairman, 17.873 aandelen Cryo- Save heeft gekocht in de periode van 23 maart tot en met 26 maart 2010. De aankoopprijs lag tussen €5,60 en €5,84.
    26/03/2010Director/PDMR ShareholdingCryo-Save Group N.V., Europe’s leading stem cell bank, has been informed that on 25 March 2010 Marc Waeterschoot, Chief Executive Officer, transferred 100,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) from Life-Sciences N.V., a company controlled by him, into his personal Cryo-Save holdings.
    22/03/2010Cryo-Save Full Year ResultsCryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save", or "the Group"), Europe's leading adult stem cell storage bank, has published its full year results for the year to 31 December 2009.
    22/03/2010Cryo-Save Full Year Results (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save", of "de Groep"), de grootste stamcelbank van Europa, maakt haar resultaten bekend over het boekjaar eindigend op 31 December 2009.
    19/03/2010Non-Executive Director appointmentCryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that Dr. Ronald H.W. Lorijn will be appointed as Non-Executive Director...
    19/03/2010Non-Executive Director appointment (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO), Europa’s grootste stamcelbank, maakt bekend dat dr. Ronald H.W. Lorijn (58) (MD, PhD, MBA) zal worden voorgedragen voor benoeming tot Non-Executive Director...
    26/02/2010Acquisition of minority shareholdingsCryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has acquired the remaining 30% minority shareholding of its...
    26/02/2010Acquisition of minority shareholdings (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, heeft het resterende 30% minderheidsbelang gekocht van haar...
    24/02/2010Notice of Full Year resultsCryo-Save Group NV, (AIM: CRYO), Europe's largest adult stem cell storage bank, will be publishing its Full Year results for the 12 months ended 31 December 2009 on Monday, 22 March 2010.
    24/02/2010Notice of Full Year results (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, zal haar resultaat over het jaar eindigend op 31 december 2009 publiceren op maandag 22 maart 2010.
    04/02/2010New CEO AppointmentCryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has appointed Arnoud van Tulder (48) as Chief Executive Officer with effect from 1 May 2010.
    04/02/2010New CEO Appointment (Dutch Version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, kondigt aan dat Arnoud van Tulder (48), momenteel Chief Financial Officer van de Groep, met ingang van 1 mei 2010 zal worden benoemd tot Chief Executive Officer.
    27/01/2010Board ChangeCryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, announces that Werner Spinner, a non-executive director, has resigned from the Board with immediate effect.
    27/01/2010Board Change (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, maakt bekend dat Werner Spinner met ingang van heden is teruggetreden als non-executive director uit de Board of Directors.
    19/01/2010Successful completion of Cord Blood expansion project between Cryo-Save and Etablissement Francais Du Sang, FranceCryo-Save, Europe's leading stem cell bank, is pleased to announce the successful completion of a collaborative project with EFS...
    13/01/2010Transfer of Treasury SharesCryo-Save Group (AIM/Euronext: CRYO or “the Group”) announces that, on 12 January 2010, 20,000 ordinary shares have been transferred from treasury shares...
    07/01/2010Q4 2009 sample storage resultsCryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, stored over 7,300 samples in Q4 2009, up 18% over Q4 2008 (6,200 samples).
    07/01/2010Q4 2009 sample storage results (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, heeft in het vierde kwartaal van 2009 meer dan 7.300 nieuwe stalen uit navelstrengbloed van pasgeboren babies opgeslagen. Dit is een toename van meer dan 18% ten opzichte van dezelfde periode van 2008 (6.200 bloedstalen) en betekent een record voor de Groep.
    10/12/2009Cryo-Save welcomes new proposed French Law supporting Cord Blood bankingCryo-Save, Europe's leading stem cell bank, notes and welcomes the announcement of proposed new legislation in France...
    22/10/2009Admission to trading on EuronextCryo-Save Group N.V. (AIM/EURONEXT: CRYO, “Cryo-Save”, “the Company”), Europe’s leading stem cell bank, today announces commencement of dealings of its ordinary shares on Euronext Amsterdam by NYSE Euronext.
    13/10/2009Publication of the Prospectus and listing on Euronext AmsterdamCryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Company”), Europe’s leading stem cell bank, announces that it has published today its prospectus as approved by the Netherlands Authority for the Financial Markets (Stichting Autoriteit Financiële Markten, "AFM") regarding the additional Euronext Amsterdam listing.
    08/10/2009Share consolidation announcementCryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Company”), Europe’s leading stem cell bank, confirms that pursuant to the passing of the relevant resolutions at an EGM of the Company held on 5 October 2009, and as notified on that day, the proposed 5:1 share consolidation has this morning become effective.
    06/10/2009Q3 2009 sample storage resultsCryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, has published its Q3 2009 sample storage numbers for the quarter to 30 September 2009.
    06/10/2009EGM resolutions and share consolidationThe Group is on course to secure its additional listing on Euronext Amsterdam by mid October to complement the Group’s shares being traded on AIM in London.
    18/09/2009Cryo-Save convenes EGMCryo-Save convenes EGM in relation to intended Euronext Amsterdam listing and proposed share consolidation.
    15/09/2009Half year results 2009Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, has published interim results for the six months to 30 June 2009.
    03/09/2009Cryo-Save plans to list on EuronextCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save”), Europe's leading stem cell bank, plans to seek an additional listing on Euronext Amsterdam in the fourth quarter of the current financial year to complement the Group’s shares being traded on AIM in London.
    14/08/2009Transaction in Own SharesThe Board of Cryo-Save announces that, pursuant to authorities granted by shareholders at the Company's Annual General Meeting held on 20 May 2009, the Company purchased 100,000 Ordinary Shares of Euro 0.02.
    10/08/2009Notice of ResultsCryo-Save Group NV, (AIM: CRYO, 'the Company'), Europe's largest adult stem cell storage bank, will be publishing its Interim Results for the six months ended 30 June 2009 on Tuesday, 15 September 2009.
    14/07/2009Completion of AcquisitionFurther to the announcement made on 27 May 2009, Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, is pleased to announce the completion of the acquistion of Salus Futura Ltd.
    07/07/2009Q2 Storage FiguresCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has published its Q2 2009 sample storage numbers for the quarter to 30 June 2009.
    03/07/2009Distribution agreementCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save"), Europe's leading stem cell bank, has signed an exclusive distribution agreement for the Iberian market with the Spanish subsidiary of Labco, a leading pan European medical diagnostic labs network.
    16/06/2009Directorate ChangeCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that Rob Koremans has resigned in order to take up a senior position with a leading pharmaceutical company.
    27/05/2009Acquisition of Italian service companyCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that it has agreed to acquire Salus Futura Ltd, United Kingdom, which holds all shares of Salus Futura Srl, Italy ("Salus Futura").
    20/05/2009AGM ResolutionsCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that all resolutions at today's AGM were passed.
    29/04/2009Holding(s) in CompanyTR-1: Notifications of Major Interests in Shares
    28/04/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's leading stem cell bank, has been informed that on 24 April 2009 Mr Werner Spinner, Non-Executive Director, purchased 25,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 77.24 pence per share.
    27/04/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's leading stem cell bank, has been informed that on 23 April 2009 Mr Walter van Pottelberge, Non-Executive Director, purchased 25,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 63.5 pence per share.
    24/04/2009Grant of OptionsCryo-Save Group N.V. ("Cryo-Save" or "the Company"), Europe's leading stem cell bank, announces that on 23 April 2009 the Company granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2007 Share Option Scheme.
    23/04/2009Annual Report and AccountsThe Company confirms that its annual report and accounts for the year ended 31 December 2008 has been posted to shareholders and is also available on the Company's website www.cryo-savegroup.com.
    22/04/2009Sale and lease backCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has signed a sale and lease back agreement for its 4,500 sq. metre laboratory and storage facility in Antwerp for 4.3 million and a 15-year fixed lease.
    07/04/2009Q1 Storage UpdateCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has published its Q1 2009 sample storage numbers for the quarter to 31 March 2009.
    30/03/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, has been informed that Mr Arnoud van Tulder, Chief Financial Officer, has today purchased 30,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 41 pence per share.
    24/03/2009Final ResultsCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, announces its final results for the year to 31 December 2008.
    24/03/2009Director/PDMR ShareholdingsThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, has been informed that Rob Koremans, Chief Executive Officer, has today purchased 48,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at a price of 37p per share.
    12/03/2009100,000th sample under storageCryo-Save Group NV, (AIM: CRYO, 'the Company', "Cryo-Save"), Europe's largest adult stem cell storage bank, announces that it now has 100,000 stem cell samples under storage. This significant landmark was reached yesterday when the stem cells from the one hundred thousandth newborn child were safely stored in the Company's facilities.
    23/02/2009Holding(s) in CompanyTR-1: Notification of Major Interests in Shares
    23/02/2009Notice of ResultsCryo-Save Group NV, (AIM: CRYO, 'the Company'), Europe's largest adult stem cell storage bank, will be publishing its Final Results for the year ended 31 December 2008 on Tuesday, 24 March 2009.
    11/02/2009Proposed dividendCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that the Board plans to propose a maiden dividend of 0.01 per share for the year ended 31 December 2008.
    06/02/2009Holding(s) in CompanyTR-1: Notification of Major Interests in Shares
    26/01/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, has been informed that on 23 January 2009 Mr Werner Spinner, Non-Executive Director, purchased 50,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 39 pence per share.
    22/01/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, has been informed that on 20 January 2009 Mr Marc Waeterschoot,Executive Chairman, purchased 101,100 ordinary shares of Euro 0.02 ("Ordinary Shares") at 39 pence per share.
    20/01/2009Transaction in Own SharesThe Board of Cryo-Save announces that the Company has today purchased 50,000 Ordinary Shares of Euro 0.02 ("Ordinary Shares") at a price of 39 pence per share to be held in Treasury.
    19/01/2009Transaction in Own SharesThe Board of Cryo-Save announces that the Company purchased 50,000 Ordinary Shares of Euro 0.02 ("Ordinary Shares") on 16 January 2009 at a price of 37.5 pence per share to be held in Treasury and 150,000 Ordinary Shares on 19 January 2009 at a price of 39 pence per share, also to be held in Treasury.
    13/01/2009Holding(s) in CompanyTR-1: Notification of Major Interests in Shares
    08/01/2009Trading updateCryo-Save Group N.V. (AIM: CRYO), Europe's leading stem cell bank, has published its 2008 including Q4 sample storage numbers for the quarter to 31 December 2008.
    06/01/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, was informed on 5 January 2009 that Mr Werner Spinner, Non-Executive Director, purchased 75,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 32 pence per share between 29 December 2008 and 2 January 2009.
    		  
      europe flag
    Europe's leading stem cell bank -
    4 laboratories - 39 countries -
    3 continents


    Use of this website signifies your agreement to the Disclaimer.
    ©2009 Cryo-Save Group N.V. All rights reserved.